InsiderSignal.AI

InsiderSignal.ai

CLDI - Calidi Biotherapeutics, Inc.

Insider Purchase by Schoeneck James A (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Schoeneck James A, serving as Dir at Calidi Biotherapeutics, Inc. (CLDI), purchased 75,000 shares at $2.00 per share, for a total transaction value of $150,000.00. Following this transaction, Schoeneck James A now holds 84,514 shares of CLDI.

This purchase represents a 788.00% increase in Schoeneck James A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 21, 2025 and publicly disclosed via SEC Form 4 filing on Monday, August 25, 2025, 4 days after the trade was made.

Calidi Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Schoeneck James A

Dir

James A. Schoeneck is a seasoned biotechnology executive serving as Chairman of the Board and Director of Calidi Biotherapeutics, Inc. (CLDI) since July 2020, with his role as Chairman beginning in April 2025.[[2]](https://www.calidibio.com/team/james-a-schoeneck/) He is also a Director at FibroGen, Inc. since April 2010, where he acted as Interim CEO from 2019 to 2020, and previously served as CEO of Depomed, Inc. from 2011 to 2017, transforming it into a commercial specialty pharmaceutical company.[[1]](https://insiderinsights.com/free/index.php?s=filer&o=-1&a=&q=Schoeneck+James+A)[[2]](https://www.calidibio.com/team/james-a-schoeneck/)[[5]](https://www.insidertrades.com/fibrogen-inc-stock/james-a-schoeneck/) Schoeneck's career highlights include CEO roles at BrainCells Inc. (2005-2011), ActivX BioSciences, and Prometheus Laboratories Inc., as well as Vice President and General Manager of Immunology at Centocor, Inc., where he oversaw the launch of Remicade®.[[2]](https://www.calidibio.com/team/james-a-schoeneck/) Earlier, he held increasing sales and marketing responsibilities at Rhone-Poulenc Rorer, Inc. (now Sanofi) for 13 years. He holds a BS in Education from Jacksonville State University.[[2]](https://www.calidibio.com/team/james-a-schoeneck/)

View full insider profile →

Trade Price

$2.00

Quantity

75,000

Total Value

$150,000.00

Shares Owned

84,514

Trade Date

Thursday, August 21, 2025

185 days ago

SEC Filing Date

Monday, August 25, 2025

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Calidi Biotherapeutics, Inc.

Company Overview

No company information available
View news mentioning CLDI

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/154720

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime